• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Abbott Laboratories

Abbott Laboratories

Abbott Laboratories ABT 3 Star

Last Price$45.65Day Change (%)-1.50%
Open Price$46.33Day Change ($)-0.70
Day Range45.58–46.3752-Week Range36.65–47.88

As of Wed 4/1/2015 3:22:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Analog Devices gains on upgrade; Altera slides

    UPDATE: Analog Devices gains on upgrade; Altera slides

  2. Top 10 Buys and Sells by the Ultimate Stock-Pickers

    A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.

  3. Research and Markets: Germany Healthcare, Regulatory and Reimbursement Landscape Report 2015

    Research and Markets: Germany Healthcare, Regulatory and Reimbursement Landscape Report 2015

  4. Mylan N.V. Announces Pricing of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

    Mylan N.V. Announces Pricing of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

  5. Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

    Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

  6. Diversifying in a Shrinking World

    Simple formulas for foreign exposure lose luster.

  7. Bad Investor Behavior: Overemphasizing Experience

    Abbott Labs ABT had a strong showing at the American College of Cardiology's annual meeting this weekend, but the news was less positive for Boston Scientific BSX and partner Angiotech ANPI. Abbott revealed data from a head-to-head trial that demonstrated its Xience V drug-eluting stent performed ...

  8. Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States

    Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States

  9. AbbVie And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy

    AbbVie And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy

  10. Research and Markets: Australia Sleep Apnea Diagnostic Systems Market Growth Trends Report 2015

    Research and Markets: Australia Sleep Apnea Diagnostic Systems Market Growth Trends Report 2015

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.